Neurobiology and Clinical Neuroscience
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the treatment of neurobiology and neurologic diseases. Topics include, but are not limited to neurogenesis, neuroplasticity, neuropharmacology, and neurotherapeutics, in vitro and in vivo responses to neurological diseases, identification of therapeutic targets, evaluation of diagnostic markers, and assessment of therapies for neurological disorders.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Interplays between Metabolic Disorders and Neurological Diseases (Deadline: 30 April 2024)
- Aging and Neuroendocrinological Diseases (Deadline: 30 April 2024)
- Molecular Mechanisms and Therapy of Gliomas (Deadline: 30 April 2024)
- Brain Imaging and Cognitive Deficits in Psychiatric Disorders (Deadline: 30 April 2024)
- Amyloid Pathology: Cellular Mechanism and Therapy Targets (Deadline: 30 April 2024)
- Growth Factors of the Peripheral Nervous System and Neurotrophin Family (Deadline: 30 April 2024)
- 10th Anniversary of Biomedicines—Advances in Multiple Sclerosis (Deadline: 30 April 2024)
- Application of Animal Models and New Therapeutic Approaches in Neurological Diseases (Deadline: 30 April 2024)
- Emerging Challenges: Neurological Manifestations of Systemic Diseases and Medication-Induced Neurological Disorders (Deadline: 30 April 2024)
- Dualistic Equilibrium in Neurotransmission and Beyond: Unraveling the Pathophysiology and Unlocking Novel Therapeutic Targets in Neuropsychiatric Disorders (Deadline: 30 April 2024)
- Emerging Trends in Brain Stimulation (Deadline: 30 April 2024)
- Advanced in Schizophrenia Research and Treatment (Deadline: 30 April 2024)
- Autonomic Dysfunction in Neurological Disorders: Novel Mechanisms and Targets (Deadline: 30 April 2024)
- Biomarkers in Neurological Disorders (Deadline: 31 May 2024)
- Novel Approaches to the Regeneration and Repair of the Nervous System: Neuronal Reprogramming (Deadline: 31 May 2024)
- Neurodegenerative Diseases: From Mechanisms to Therapeutic Approaches (Deadline: 31 May 2024)
- Molecular Mechanisms of Neurological Autoimmune Disorders Volume II (Deadline: 31 May 2024)
- Alzheimer's Disease Genetics (Deadline: 31 May 2024)
- Animal and Cellular Models of Alzheimer’s Disease, 2nd Edition (Deadline: 31 May 2024)
- Parkinson’s Disease: From Pathophysiology to Novel Therapeutic Approaches—Second Edition (Deadline: 31 May 2024)
- Advances in Pharmacotherapy of Alzheimer’s Disease (Deadline: 31 May 2024)
- Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach 3.0 (Deadline: 30 June 2024)
- Research on Pharmacotherapy for Neuropathic Pain (Deadline: 30 June 2024)
- Advances in Targeted Therapy of Neuroblastoma (Deadline: 30 June 2024)
- Long Noncoding RNAs in Brain Diseases (Deadline: 30 June 2024)
- State-of-the-Art Pain Medicine (Deadline: 30 June 2024)
- Glycine-(and D-Serine)-Related Neurotransmission: Promising Therapeutic Targets with Still Unsolved Problems (Deadline: 30 June 2024)
- Biomedical and Biochemical Basis of Neurodegenerative Diseases (Deadline: 30 June 2024)
- Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical, and Translational Neuropsychiatry—Second Edition (Deadline: 30 June 2024)
- Advancements in Antipsychotics (Deadline: 30 June 2024)
- Animal Models of Neurological Disorders: Where Are We Now? (2nd Edition) (Deadline: 30 June 2024)
- Crosstalk between Depression, Anxiety, Dementia, and Chronic Pain: Comorbidity in Behavioral Neurology and Neuropsychiatry Volume III (Deadline: 31 July 2024)
- Regulatory T Cells in Neuroimmunological Disease Therapeutics (Deadline: 31 July 2024)
- Epigenetic Mechanisms of Postoperative Cognitive Impairment Induced by Anesthesia and Neuroinflammation (Deadline: 31 July 2024)
- New Molecular Insights into the Pathogenesis and Drug Development of Neurodegenerative Diseases (Deadline: 31 July 2024)
- Recent Advances in Craniofacial Pain and Headaches—Second Edition (Deadline: 31 July 2024)
- Pharmacological Targets for Neuroinflammation (Deadline: 31 July 2024)
- Mitochondrial Dysfunction and Oxidative Stress (Deadline: 31 July 2024)
- Spinal Cord Compression: Molecular, Cellular and Therapeutic Aspects (Deadline: 31 July 2024)
- Biomarkers in Dementia Disorders (Deadline: 31 July 2024)
- Genetic Research on Neurodevelopmental Disorders (Deadline: 31 July 2024)
- Neuroinflammation: From Pathophysiologic Mechanisms to Therapeutic Strategies (Deadline: 31 July 2024)
- Molecular Research in Neuropharmacology (Deadline: 31 July 2024)
- Diagnosis, Pathogenesis, Treatment and Prognosis of Glioblastoma (Deadline: 31 July 2024)
- Ferroptosis Pathways in Neurodegenerative and Neuropsychiatric Diseases (Deadline: 15 August 2024)
- Emerging Trends in Neurostimulation and Neuromodulation Research (Deadline: 31 August 2024)
- Mechanisms and Novel Therapeutic Approaches for Neurodegenerative Diseases (Deadline: 31 August 2024)
- Understanding Diseases Affecting the Central Nervous System (Deadline: 31 August 2024)
- Neuropeptides, Dopamine and Their Interactions in Neuroscience (2nd Edition) (Deadline: 31 August 2024)
- Molecular Characteristics of Cerebral Ischemia and Their Therapeutic Applications (Deadline: 31 August 2024)
- Molecular Mechanism of Amyloid Aggregation (Deadline: 31 August 2024)
- Neurocognitive Disorder: Diagnostic Methods, Treatment Challenges and Future Directions (Deadline: 31 August 2024)
- Inflammation and Peripheral Nervous System (Deadline: 31 August 2024)
- Neuroendocrine Neoplasia and Endocrine Tumors: Pathogenic Features, Prognostic Markers and New Therapeutic Approaches (Deadline: 31 August 2024)
- Pain–Neuroinflammation Dyad: New Therapeutic Strategies or Pharmacological Targets to Counter Them (Deadline: 31 August 2024)
- Pathophysiological Mechanisms of Parkinson's Disease (Deadline: 31 August 2024)
- Oxidative Stress and Proteinopathy in Alzheimer's Disease (Deadline: 30 September 2024)
- Advancements in Neuroscience: A Special Issue in Honour of Ramón Y Cajal (Deadline: 30 September 2024)
- Neurotrauma: Mechanisms, Pathways, and Emerging Therapeutic Interventions (Deadline: 30 September 2024)
- Brain Injury: New Insights into Mechanisms and Future Promising Treatments (Deadline: 30 September 2024)
- Understanding Chronic Neurological Diseases: Pathophysiology, Biomarkers, and Therapeutic Approaches (Deadline: 30 September 2024)
- Recent Therapeutic Advances in Parkinson’s Disease (Deadline: 30 September 2024)
- Protein Misfolding and Functional Impairment in Neurodegenerative Diseases (Deadline: 30 September 2024)
- Alzheimer's Disease—115 Years after Its Discovery 2.0 (Deadline: 30 September 2024)
- Current Aspects on the Therapeutics of Aging, Cellular Senescence and Neurodegenerative Diseases (Deadline: 30 September 2024)
- Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches—2nd Edition (Deadline: 30 September 2024)
- Glioblastoma: Pathogenetic, Diagnostic and Therapeutic Perspectives (Deadline: 30 September 2024)
- Advances in Molecular and Translational Research between Cognitive Function and Physical Activity (Deadline: 15 October 2024)
- Molecular Research of Neurological and Psychiatric Disorders (Deadline: 31 October 2024)
- Biomarkers for Neurodegenerative Disorders: From Bench to Bedside (Deadline: 31 October 2024)
- The Role of Amyloids in Neurodegenerative Diseases: Current Insights and Future Perspectives (Deadline: 31 October 2024)
- Encephalitis and Viral Infection: Mechanisms and Therapies (Deadline: 30 November 2024)
- State of the Art: Prerequisites, Prevention and Treatment of Neurodegenerative Diseases (Deadline: 31 December 2024)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Feature Papers in Neuromodulation and Brain Stimulation
- Nervous System Inflammation
- Neurodegeneration No More: Cutting-Edge Technologies and Therapies in the Evolution of Neurodegenerative Disease Management
- Neurodevelopmental Disorders: From Pathophysiology to Treatment
- Neurogenic Neuroinflammation in Fibromyalgia
- Neurotoxicity: Mechanisms and Potential Therapeutic Strategies (Closed)
